Report cover image

Ad Scientiam - Product Pipeline Analysis, 2022 Update

Publisher GlobalData
Published Feb 07, 2023
Length 38 Pages
SKU # GBDT17776232

Description

Summary

Ad Scientiam is a medical technology company, that offers digital biomarkers which collects physiological and behavioral data. It provides mobile application which monitors patients’ behaviors and sharers the data to healthcare professionals. Ad Scientiam serves individuals, healthcare professionals and pharmaceutical companies. The company’s solution finds application in the areas of Parkinson disease, Asthma, Atopic Dermatisi, Insomnia, Multiple Sclerosis, Oncology and Alzheimer's disease among others. It also operates an office in the US. Ad Scientiam is headquartered in Paris, Ile de France, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Ad Scientiam
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

38 Pages
Ad Scientiam Company Overview
Ad Scientiam Company Snapshot
Ad Scientiam Pipeline Products and Ongoing Clinical Trials Overview
Ad Scientiam – Pipeline Analysis Overview
Ad Scientiam - Key Facts
Ad Scientiam - Major Products and Services
Ad Scientiam Pipeline Products by Development Stage
Ad Scientiam Ongoing Clinical Trials by Trial Status
Ad Scientiam Pipeline Products Overview
Actisleep
Actisleep Product Overview
CARDICARE
CARDICARE Product Overview
Major Depressive Disorder Mobile App
Major Depressive Disorder Mobile App Product Overview
Major Depressive Disorder Mobile App Clinical Trial
Mobile Application - Alzheimer’s
Mobile Application - Alzheimer’s Product Overview
Mobile Application - Asthma
Mobile Application - Asthma Product Overview
Mobile Application - Insomnia
Mobile Application - Insomnia Product Overview
Mobile Application - Oncology
Mobile Application - Oncology Product Overview
Mobile Application - Parkinson’s
Mobile Application - Parkinson’s Product Overview
Mobile Application - Rheumatoid Arthritis
Mobile Application - Rheumatoid Arthritis Product Overview
Mobile Application - Schizophrenia
Mobile Application - Schizophrenia Product Overview
MSCopilot Mobile App
MSCopilot Mobile App Product Overview
OPTIS
OPTIS Product Overview
OPTIS Clinical Trial
Ad Scientiam - Key Competitors
Ad Scientiam - Key Employees
Ad Scientiam - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Ad Scientiam, Recent Developments
Oct 28, 2019: Ad Scientiam tracks valuable digital biomarkers for clinical research
Jan 29, 2019: Ad Scientiam selected for Pfizer Acceleration Program
Nov 14, 2018: Ad Scientiam announces clinical validation of its MSCopilot solution
Nov 14, 2018: Ad Scientiam, a french startup hosted at the Brain & Spine Institute (paris), announces clinical validation of its MSCopilot solution
Jul 18, 2018: MyHBP, application dedicated to the monitoring of benign prostatic hypertrophy
Jul 18, 2018: TLM : new version of MSCopilot
Jul 17, 2018: Ad Scientiam selected for EIT Health GoGlobal Canada Programme
Jun 08, 2018: Altran accompanies Ad Scientiam on the European compliance of MSCopilot
Jun 01, 2018: The 16 Health start-ups selected by Product Market Fit
May 30, 2018: MSCopilot is evolving for World MS Day
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Ad Scientiam Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Ad Scientiam Pipeline Products by Equipment Type
Table 3: Ad Scientiam Pipeline Products by Indication
Table 4: Ad Scientiam, Key Facts
Table 5: Ad Scientiam, Major Products and Services
Table 6: Ad Scientiam Number of Pipeline Products by Development Stage
Table 7: Ad Scientiam Pipeline Products Summary by Development Stage
Table 8: Ad Scientiam Ongoing Clinical Trials by Trial Status
Table 9: Ad Scientiam Ongoing Clinical Trials Summary
Table 10: Actisleep - Product Status
Table 11: Actisleep - Product Description
Table 12: CARDICARE - Product Status
Table 13: CARDICARE - Product Description
Table 14: Major Depressive Disorder Mobile App - Product Status
Table 15: Major Depressive Disorder Mobile App - Product Description
Table 16: Major Depressive Disorder Mobile App - Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale
Table 17: Mobile Application - Alzheimer’s - Product Status
Table 18: Mobile Application - Alzheimer’s - Product Description
Table 19: Mobile Application - Asthma - Product Status
Table 20: Mobile Application - Asthma - Product Description
Table 21: Mobile Application - Insomnia - Product Status
Table 22: Mobile Application - Insomnia - Product Description
Table 23: Mobile Application - Oncology - Product Status
Table 24: Mobile Application - Oncology - Product Description
Table 25: Mobile Application - Parkinson’s - Product Status
Table 26: Mobile Application - Parkinson’s - Product Description
Table 27: Mobile Application - Rheumatoid Arthritis - Product Status
Table 28: Mobile Application - Rheumatoid Arthritis - Product Description
Table 29: Mobile Application - Schizophrenia - Product Status
Table 30: Mobile Application - Schizophrenia - Product Description
Table 31: MSCopilot Mobile App - Product Status
Table 32: MSCopilot Mobile App - Product Description
Table 33: OPTIS - Product Status
Table 34: OPTIS - Product Description
Table 35: OPTIS - Performance and Safety of a Digital Tool for Unsupervised Self-assessment of Neuromyelitis Optica Spectrum Disorder
Table 36: Ad Scientiam, Key Employees
Table 37: Ad Scientiam, Other Locations
Table 38: Glossary
List of Figures
Figure 1: Ad Scientiam Pipeline Products by Equipment Type
Figure 2: Ad Scientiam Pipeline Products by Development Stage
Figure 3: Ad Scientiam Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us